Anindita (Annie) Saha is Associate Director for Strategic Initiatives for the Digital Health Center of Excellence (DHCoE) in the Center for Devices and Radiological Health at FDA where she supports promoting innovation of digital health technologies, including those enabled by artificial intelligence. She is also serving as the acting Associate Director for Data Science and Artificial Intelligence Policy at the FDA Center for Drug Evaluation and Research to support the use of AI across the drug development lifecycle. Additionally, Annie helped incubate and continues to support to advance the science and adoption of patient input as evidence, including patient preference information (PPI), clinical outcome assessments (COAs). Previously, Annie was the Director of the Partnerships team in CDRH where she oversaw a broad program portfolio, supporting several strategic partnership and regulatory science programs. Ms. Saha started as a researcher in the Office of Science and Engineering Laboratories in imaging display technologies. Ms. Saha has a Bachelor of Science in Bioengineering and Minor in History from the University of Pittsburgh.